---
figid: PMC5662584__fphar-08-00761-g0004
figlink: /pmc/articles/PMC5662584/figure/F4/
number: Figure 4
caption: Proposed mechanisms involved in in vitro anticancer activity of surfactin.
  The anticancer activity of surfactin is associated with growth inhibition, cell
  cycle arrest, cell death (apoptosis), and metastasis inhibition. Surfactin treatment
  can inhibit cancer cell viability by inactivating the cell survival signaling pathways.
  Besides, surfactin regulates cell cycle-regulatory proteins, which are pivotal for
  cell cycle phase transition to block the proliferation of cancer cells. The apoptotic
  effect (intrinsic mitochondrial/caspase pathway) of surfactin is mediated by two
  different pathways that are triggered by high intracellular ROS formation, namely
  ERS/[Ca2+]i/ERK1/2 and JNK/ΔΨm /[Ca2+]i/Bax-to-Bcl-2 ratio/cyt c pathways. Surfactin-induced
  apoptosis is also associated with the changes in phospholipids composition that
  leads to a significant decrease in unsaturated degree of cellular fatty acids. Apart
  from these, surfactin also inhibits the invasion, migration and colony formation
  of cancer cells in the virtue of MMP-9 expression change that involves the inactivation
  of NF-κB, AP-1, PI3K/Akt, and ERK1/2 signaling pathways.
pmcid: PMC5662584
papertitle: Anticancer Activities of Surfactin and Potential Application of Nanotechnology
  Assisted Surfactin Delivery.
reftext: Yuan-Seng Wu, et al. Front Pharmacol. 2017;8:761.
pmc_ranked_result_index: '17778'
pathway_score: 0.9562786
filename: fphar-08-00761-g0004.jpg
figtitle: Proposed mechanisms involved in in vitro anticancer activity of surfactin
year: '2017'
organisms: Homo sapiens
ndex: 97f29e7a-dedd-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5662584__fphar-08-00761-g0004.html
  '@type': Dataset
  description: Proposed mechanisms involved in in vitro anticancer activity of surfactin.
    The anticancer activity of surfactin is associated with growth inhibition, cell
    cycle arrest, cell death (apoptosis), and metastasis inhibition. Surfactin treatment
    can inhibit cancer cell viability by inactivating the cell survival signaling
    pathways. Besides, surfactin regulates cell cycle-regulatory proteins, which are
    pivotal for cell cycle phase transition to block the proliferation of cancer cells.
    The apoptotic effect (intrinsic mitochondrial/caspase pathway) of surfactin is
    mediated by two different pathways that are triggered by high intracellular ROS
    formation, namely ERS/[Ca2+]i/ERK1/2 and JNK/ΔΨm /[Ca2+]i/Bax-to-Bcl-2 ratio/cyt
    c pathways. Surfactin-induced apoptosis is also associated with the changes in
    phospholipids composition that leads to a significant decrease in unsaturated
    degree of cellular fatty acids. Apart from these, surfactin also inhibits the
    invasion, migration and colony formation of cancer cells in the virtue of MMP-9
    expression change that involves the inactivation of NF-κB, AP-1, PI3K/Akt, and
    ERK1/2 signaling pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3CA
  - PIK3CB
  - FOS
  - FOSB
  - FOSL2
  - CASP8
  - CASP10
  - PIK3CG
  - PIK3R3
  - BAX
  - PIK3CD
  - AKT2
  - PIK3R6
  - PIK3R5
  - AKT1
  - CCNE2
  - BCL2
  - CASP9
  - PIK3R4
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - JUND
  - JUN
  - JUNB
  - CDK2
  - CCNE1
  - CASP14
  - MAPK3
  - MAPK1
  - CASP12
  - AKT3
  - CASP1
  - AFM
  - FOSL1
  - CASP3
  - MAPK10
  - MAPK8
  - CASP2
  - MMP9
  - TP53
  - MAPK9
  - NFKB1
  - MPTP
  - Cancer
genes:
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOS
  entrez: '2353'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSB
  entrez: '2354'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL2
  entrez: '2355'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Bax
  symbol: BAX
  source: hgnc_symbol
  hgnc_symbol: BAX
  entrez: '581'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE2
  entrez: '9134'
- word: BCL-2
  symbol: Bcl-2
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2
  entrez: '596'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: PI3K/Akt
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUND
  entrez: '3727'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUN
  entrez: '3725'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: JUNB
  entrez: '3726'
- word: CDK2
  symbol: CDK2
  source: hgnc_symbol
  hgnc_symbol: CDK2
  entrez: '1017'
- word: CyclinE
  symbol: Cyclin_E
  source: bioentities_symbol
  hgnc_symbol: CCNE1
  entrez: '898'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: ERK1/2
  symbol: ERK1
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: ERK1/2
  symbol: ERK2
  source: hgnc_alias_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: PI3K/Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: AFm
  symbol: AFM
  source: hgnc_symbol
  hgnc_symbol: AFM
  entrez: '173'
- word: AP-1
  symbol: AP1
  source: bioentities_symbol
  hgnc_symbol: FOSL1
  entrez: '8061'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: MMP-9
  symbol: MMP9
  source: hgnc_symbol
  hgnc_symbol: MMP9
  entrez: '4318'
- word: p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: JNK
  symbol: JNK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
chemicals:
- word: MPTP
  source: MESH
  identifier: D015632
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
